Arcturus Therapeutics Holdings Inc Equity-NMS: ARCT

$7.97 0.46 (February 20, 2026)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$7.51
Open :$7.5
Today's high :$8
Today's low :$7.45
52W low :$5.85
52W high :$24.17
1Y :-55.6%
5Y :-88.17%
EPS(TTM): :-2.46
Shares O/S :28.41 M
Market cap :226.46 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Arcturus Therapeutics Holdings Inc today?

Arcturus Therapeutics Holdings Inc (ARCT) share price as of February 20, 2026, is $7.97. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Arcturus Therapeutics Holdings Inc?

Yes, Indian Investors can invest in the Arcturus Therapeutics Holdings Inc (ARCT) Share by opening an international trading account with Angel One.

How can I purchase Arcturus Therapeutics Holdings Inc shares in India?

Purchasing Arcturus Therapeutics Holdings Inc (ARCT) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Arcturus Therapeutics Holdings Inc (ARCT) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Arcturus Therapeutics Holdings Inc?

Yes, you can purchase fractional shares of Arcturus Therapeutics Holdings Inc (ARCT) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Arcturus Therapeutics Holdings Inc?

The market capitalization of Arcturus Therapeutics Holdings Inc on February 20, 2026, is $226.46 M.

In which sector Arcturus Therapeutics Holdings Inc belongs?

Arcturus Therapeutics Holdings Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Arcturus Therapeutics Holdings Inc stocks?

In order to invest in Arcturus Therapeutics Holdings Inc (ARCT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Inc. is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. The Company with enabling technologies, including LUNAR lipid-mediated delivery, STARR mRNA technology (sa-mRNA) and mRNA drug substances along with drug product manufacturing. It has developed KOSTAIVE, a self-amplifying messenger RNA (sa-mRNA) COVID vaccine. The Company’s pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. The Company's versatile RNA therapeutics platforms can be applied to multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.